Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

Clinical trial NCT06627179 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06627179
Sponsor: Laboratoires Thea
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Retinitis Pigmentosa (RP)Usher Syndrome Type 2 Deaf Blind Retinal Disease Eye Diseases, Hereditary Eye Disorders Congenital Vision Disorders

Start date: 2024-12-11
Primary completion: 2028-07-01
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.